Early P2Y₁₂ Receptor Monotherapy Following Drug-Eluting Stenting: Is It Time to Give Up Aspirin?

Affiliations

Editorial

Carlo Briguori. Circ Cardiovasc Interv. 2021 May.

. 2021 May;14(5):e010880.

doi: 10.1161/CIRCINTERVENTIONS.121.010880. Epub 2021 May 18.

No abstract available

Keywords: Editorials; aspirin; clopidogrel; percutaneous coronary intervention; stent.

Comment on

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 Trial.
Yamamoto K, Watanabe H, Morimoto T, Domei T, Ohya M, Ogita M, Takagi K, Suzuki H, Nikaido A, Ishii M, Fujii S, Natsuaki M, Yasuda S, Kaneko T, Tamura T, Tamura T, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Igarashi Hanaoka K, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Yamamoto K, et al. Circ Cardiovasc Interv. 2021 May;14(5):e010384. doi: 10.1161/CIRCINTERVENTIONS.120.010384. Epub 2021 May 18. Circ Cardiovasc Interv. 2021. PMID: 34003662